151 related articles for article (PubMed ID: 16988626)
1. [Treatment of subfoveal choroidal neovascularization in pathologic myopia with photodynamic therapy: outcomes at 1 and 2 years of follow-up].
El Matri L; Bouraoui R; Merdassi A; Baccouri R; Mghaieth F; Ben Rejeb S; Meddeb S
J Fr Ophtalmol; 2006 Sep; 29(7):765-70. PubMed ID: 16988626
[TBL] [Abstract][Full Text] [Related]
2. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
Blinder KJ; Blumenkranz MS; Bressler NM; Bressler SB; Donato G; Lewis H; Lim JI; Menchini U; Miller JW; Mones JM; Potter MJ; Pournaras C; Reaves A; Rosenfeld P; Schachat AP; Schmidt-Erfurth U; Sickenberg M; Singerman LJ; Slakter JS; Strong HA; Virgili G; Williams GA
Ophthalmology; 2003 Apr; 110(4):667-73. PubMed ID: 12689884
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
Verteporfin in Photodynamic Therapy Study Group
Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
[TBL] [Abstract][Full Text] [Related]
5. Two years follow-up outcome of verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia in Indian eyes.
Hussain N; Khanna R; Das T; Narayanan R; Sunday OT; Bansal AG; Reddy R
Indian J Ophthalmol; 2008; 56(6):465-8. PubMed ID: 18974516
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
7. Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.
Costagliola C; Campa C; Incorvaia C; Parmeggiani F; Menzione M; Della Corte M; Rinaldi M; Romano M; Semeraro F
Eur J Ophthalmol; 2008; 18(6):955-9. PubMed ID: 18988168
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
Pece A; Isola V; Vadalà M; Matranga D
Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.
Axer-Siegel R; Ehrlich R; Weinberger D; Rosenblatt I; Shani L; Yassur Y; Priel E; Kramer M
Am J Ophthalmol; 2004 Oct; 138(4):602-7. PubMed ID: 15488787
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia.
Ergun E; Heinzl H; Stur M
Am J Ophthalmol; 2004 Sep; 138(3):434-8. PubMed ID: 15364227
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.
Barbazetto I; Burdan A; Bressler NM; Bressler SB; Haynes L; Kapetanios AD; Lukas J; Olsen K; Potter M; Reaves A; Rosenfeld P; Schachat AP; Strong HA; Wenkstern A; ;
Arch Ophthalmol; 2003 Sep; 121(9):1253-68. PubMed ID: 12963608
[TBL] [Abstract][Full Text] [Related]
13. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group
Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
Bressler NM;
Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sickenberg M; Sternberg P; Aaberg TM; Aaberg TM; Reaves TA;
Ophthalmology; 2002 Aug; 109(8):1499-505. PubMed ID: 12153802
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia.
Bandello F; Lanzetta P; Battaglia Parodi M; Roman-Pognuz D; Saviano S; Ravalico G
Graefes Arch Clin Exp Ophthalmol; 2003 Jul; 241(7):567-570. PubMed ID: 12819976
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for juxtafoveal choroidal neovascularization in myopic eyes.
Cohen SY; Bulik A; Dubois L; Quentel G
Am J Ophthalmol; 2003 Aug; 136(2):371-4. PubMed ID: 12888071
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
Pece A; Vadalà M; Isola V; Matranga D
Am J Ophthalmol; 2007 Mar; 143(3):449-54. PubMed ID: 17317390
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective series.
Lam DS; Liu DT; Fan DS; Lai WW; So SF; Chan WM
Eye (Lond); 2005 Aug; 19(8):834-40. PubMed ID: 15375364
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks.
Shaikh S; Ruby AJ; Williams GA
Am J Ophthalmol; 2003 Jan; 135(1):1-6. PubMed ID: 12504689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
